Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Ares Management
ARES
$31.7B
| $72.3M | 0.02% |
608,124
+34,594
| +6% | +$3.76M |
|
727
Tradeweb Markets
TW
$21.9B
| $72.2M | 0.02% |
794,675
+19,862
| +3% | +$1.77M |
|
728
Essential Utilities
WTRG
$11.3B
| $72.1M | 0.02% |
1,931,118
+162,556
| +9% | +$5.67M |
|
|
CHX
729
DELISTED
ChampionX
CHX
| $72.1M | 0.02% |
2,466,830
+40,423
| +2% | +$1.25M |
|
730
Invesco
IVZ
$13.9B
| $72M | 0.02% |
4,034,956
+136,582
| +4% | +$1.97M |
|
731
US Foods
USFD
$23.3B
| $71.9M | 0.02% |
1,582,527
+12,594
| +0.8% | +$521K |
|
732
Churchill Downs
CHDN
$6.15B
| $71.8M | 0.02% |
532,328
+16,074
| +3% | +$1.91M |
|
733
Macerich
MAC
$6.95B
| $71.8M | 0.02% |
4,654,465
+165,649
| +4% | +$1.97M |
|
734
Gen Digital
GEN
$17B
| $71.8M | 0.02% |
3,145,573
+39,729
| +1% | +$787K |
|
735
Ingredion
INGR
$6.53B
| $71.6M | 0.02% |
659,532
+8,159
| +1% | +$819K |
|
736
Trimble
TRMB
$13.3B
| $71.5M | 0.02% |
1,344,256
+37,136
| +3% | +$1.77M |
|
737
ATI
ATI
$31.6B
| $71.3M | 0.02% |
1,567,583
-14,042
| -0.9% | -$583K |
|
|
KRTX
738
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $71.2M | 0.02% |
225,060
+6,721
| +3% | +$1.31M |
|
739
Pinnacle West Capital
PNW
$12.1B
| $71.2M | 0.02% |
991,371
+28,178
| +3% | +$2.07M |
|
|
ITCI
740
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $71.2M | 0.02% |
993,813
+18,899
| +2% | +$1.09M |
|
741
United Airlines
UAL
$40.6B
| $71.2M | 0.02% |
1,725,062
+26,488
| +2% | +$1.04M |
|
742
HEICO Corp
HEI
$51.3B
| $71.1M | 0.02% |
397,423
+10,396
| +3% | +$1.76M |
|
743
Wingstop
WING
$3.07B
| $71.1M | 0.02% |
276,923
+733
| +0.3% | +$158K |
|
744
Commercial Metals
CMC
$7.91B
| $70.9M | 0.02% |
1,416,800
+31,365
| +2% | +$1.43M |
|
745
Novanta
NOVT
$6.3B
| $70.9M | 0.02% |
420,765
+8,341
| +2% | +$1.22M |
|
746
Wynn Resorts
WYNN
$10.7B
| $70.8M | 0.02% |
777,178
+2,930
| +0.4% | +$260K |
|
747
Crown Holdings
CCK
$13B
| $70.8M | 0.02% |
768,624
+19,242
| +3% | +$1.63M |
|
748
Elanco Animal Health
ELAN
$10.9B
| $70.5M | 0.02% |
4,732,872
+21,692
| +0.5% | +$246K |
|
749
Trex
TREX
$4.96B
| $70.4M | 0.02% |
850,848
+15,507
| +2% | +$1.03M |
|
750
The Mosaic Company
MOS
$7.12B
| $70.2M | 0.02% |
1,963,682
+48,883
| +3% | +$1.73M |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.